Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$47 Hold
2
﹤0.01% 740
2022
Q1
$58 Hold
2
﹤0.01% 998
2021
Q4
$57 Hold
2
﹤0.01% 868
2021
Q3
$59 Hold
2
﹤0.01% 1030
2021
Q2
$64 Hold
2
﹤0.01% 1031
2021
Q1
$64 Hold
2
﹤0.01% 862
2020
Q4
$63 Hold
2
﹤0.01% 807
2020
Q3
$53 Hold
2
﹤0.01% 739
2020
Q2
$59 Hold
2
﹤0.01% 673
2020
Q1
$64 Hold
2
﹤0.01% 680
2019
Q4
$80 Hold
2
﹤0.01% 659
2019
Q3
$78 Hold
2
﹤0.01% 637
2019
Q2
$79 Hold
2
﹤0.01% 645
2019
Q1
$83 Hold
2
﹤0.01% 588
2018
Q4
$70 Hold
2
﹤0.01% 650
2018
Q3
$72 Hold
2
﹤0.01% 634
2018
Q2
$73 Hold
2
﹤0.01% 626
2018
Q1
$67 Hold
2
﹤0.01% 562
2017
Q4
$69 Hold
2
﹤0.01% 554
2017
Q3
$68 Buy
+2
New +$68 ﹤0.01% 525

Other funds holding JBGS

Exane Derivatives's JBGS Position: Q2 2022 in Review

Exane Derivatives held its JBG SMITH (JBGS) position steady in Q2 2022 at 2 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Exane Derivatives first reported a position in JBGS in Q3 2017 and has held it in 20 quarters since. The position peaked at $83 in Q1 2019. 225 funds tracked by Wall St. Rank hold JBGS as of Q2 2022.

  • Exane Derivatives held 2 shares of JBG SMITH worth $47 as of Q2 2022.
  • Exane Derivatives left its JBG SMITH share count unchanged in Q2 2022.
  • JBG SMITH made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #740 holding.
  • Exane Derivatives first reported a position in JBG SMITH in Q3 2017 and has held it in 20 quarters since.
  • Exane Derivatives's JBG SMITH position peaked at $83 in Q1 2019.
  • 225 funds tracked by Wall St. Rank held JBG SMITH as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.